Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10067-020-05572-9 http://scihub22266oqcxt.onion/10.1007/s10067-020-05572-9 33452660!7810282!33452660     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Rheumatol 2021 ; 40 (4): 1649-1657 Nephropedia Template TP {{tp|p=33452660|t=2021. Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?|pdf=|usr=}}{{33452660}} gab.com Text Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice JO: Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33452660 #FOAvip In the early stage of the COVID-19 pandemic, Belgian health authorities endorsed the interim guidelines for the treatment of COVID-19 pneumonia: hydroxychloroquine (HCQ) recommended for treatment of hospitalized patients with moderate to severe disease. As a growing number of patients were admitted, inevitably, our internal medicine team questioned the efficacy and safety of HCQ, especially with regard to cardiac side effects. In parallel with our concerns, data regarding the safety and efficacy of HCQ were published, with discordant results and debate in the medical community. Media coverage of the possible risks and benefits of HCQ use in COVID-19 also caused confusion amongst the public. In this Perspectives in Rheumatology article, we review the use and safety of HCQ in autoimmune disease and its putative efficacy and toxicity in COVID-19. Finally, we share our concern about the future of this widely used and inexpensive drug after the COVID-19 pandemic has passed. Twit Text FOAVip Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice ????Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33452660 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33452660 #FOAvip English Wikipedia <ref>{{Cite pmid|33452660}}</ref> Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice? #MMPMID33452660 Pothen L; Yildiz H; Samnick MM; Yombi JC Clin Rheumatol 2021[Apr]; 40 (4): 1649-1657 PMID33452660show ga In the early stage of the COVID-19 pandemic, Belgian health authorities endorsed the interim guidelines for the treatment of COVID-19 pneumonia: hydroxychloroquine (HCQ) recommended for treatment of hospitalized patients with moderate to severe disease. As a growing number of patients were admitted, inevitably, our internal medicine team questioned the efficacy and safety of HCQ, especially with regard to cardiac side effects. In parallel with our concerns, data regarding the safety and efficacy of HCQ were published, with discordant results and debate in the medical community. Media coverage of the possible risks and benefits of HCQ use in COVID-19 also caused confusion amongst the public. In this Perspectives in Rheumatology article, we review the use and safety of HCQ in autoimmune disease and its putative efficacy and toxicity in COVID-19. Finally, we share our concern about the future of this widely used and inexpensive drug after the COVID-19 pandemic has passed. |*COVID-19 Drug Treatment[MESH] |Antiviral Agents/therapeutic use[MESH] |Autoimmune Diseases/*drug therapy[MESH] |Cardiotoxicity/*etiology[MESH] |Humans[MESH] |Hydroxychloroquine/*adverse effects/therapeutic use[MESH] |Lupus Erythematosus, Systemic/drug therapy[MESH] |Randomized Controlled Trials as Topic[MESH]Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset (epmc).pdf DeepDyve Pubget Overpricing